FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387138897> ?p ?o ?g. }

• W4387138897 endingPage "14646" @default.
• W4387138897 startingPage "14646" @default.
• W4387138897 abstract "T lymphoblastic leukemia (T-ALL) is an aggressive haematolymphoid malignancy comprising 15% of acute lymphoblastic leukemia (ALL). Although its prognosis has improved with intensive chemotherapy, the relapse/refractory disease still carries a dismal prognosis. Thus, there is an urgent need to develop novel therapy for T-ALL. Bortezomib, a 26S proteasome inhibitor, is licensed to treat plasma cell myeloma and mantle cell lymphoma. Due to its favorable side effect profile, it is a novel agent of research interest in the treatment of ALL. Despite an increasing number of clinical trials of bortezomib in T-ALL, its detailed mechanistic study in terms of DNA damage, cell cycle, and mitotic catastrophe remains elusive. Moreover, WEE1, a protein kinase overexpressed in ALL and involved in cell-cycle regulation, has been known to be a novel therapeutic target in many cancers. But the role of bortezomib in modulating WEE1 expression in ALL still remains elusive. In this study, we demonstrate the therapeutic efficacy of bortezomib on T-ALL primary samples and cell lines. Our findings reveal that bortezomib treatment induces DNA damage and downregulates WEE1, leading to G2-M cell-cycle progression with damaged DNA. This abnormal mitotic entry induced by bortezomib leads to mitotic catastrophe in T-ALL. In conclusion, our findings dissect the mechanism of action of bortezomib and provide further insights into the use of bortezomib to treat T-ALL. Our findings suggest the possibility of novel combination therapy using proteasome inhibitors together with DNA-damaging agents in the future, which may fill the research gaps and unmet clinical needs in treating ALL." @default.
• W4387138897 created "2023-09-29" @default.
• W4387138897 creator A5005108774 @default.
• W4387138897 creator A5011657725 @default.
• W4387138897 creator A5032402958 @default.
• W4387138897 creator A5052627673 @default.
• W4387138897 creator A5062650631 @default.
• W4387138897 creator A5065600475 @default.
• W4387138897 creator A5067999055 @default.
• W4387138897 creator A5070729891 @default.
• W4387138897 creator A5080770364 @default.
• W4387138897 date "2023-09-27" @default.
• W4387138897 modified "2023-10-17" @default.
• W4387138897 title "Bortezomib Is Effective in the Treatment of T Lymphoblastic Leukaemia by Inducing DNA Damage, WEE1 Downregulation, and Mitotic Catastrophe" @default.
• W4387138897 cites W1538955534 @default.
• W4387138897 cites W1965254621 @default.
• W4387138897 cites W1973388314 @default.
• W4387138897 cites W1990532502 @default.
• W4387138897 cites W2007935491 @default.
• W4387138897 cites W2010184965 @default.
• W4387138897 cites W2015541033 @default.
• W4387138897 cites W2023486531 @default.
• W4387138897 cites W2026235225 @default.
• W4387138897 cites W2026802402 @default.
• W4387138897 cites W2032095580 @default.
• W4387138897 cites W2038260677 @default.
• W4387138897 cites W2039374629 @default.
• W4387138897 cites W2039973219 @default.
• W4387138897 cites W2041403839 @default.
• W4387138897 cites W2043888260 @default.
• W4387138897 cites W2048043603 @default.
• W4387138897 cites W2051121908 @default.
• W4387138897 cites W2068132005 @default.
• W4387138897 cites W2068973642 @default.
• W4387138897 cites W2069160022 @default.
• W4387138897 cites W2070622422 @default.
• W4387138897 cites W2087374769 @default.
• W4387138897 cites W2093353574 @default.
• W4387138897 cites W2096228011 @default.
• W4387138897 cites W2103109966 @default.
• W4387138897 cites W2108648120 @default.
• W4387138897 cites W2116578894 @default.
• W4387138897 cites W2122599078 @default.
• W4387138897 cites W2127136362 @default.
• W4387138897 cites W2133064336 @default.
• W4387138897 cites W2138595796 @default.
• W4387138897 cites W2138741985 @default.
• W4387138897 cites W2160380481 @default.
• W4387138897 cites W2163498786 @default.
• W4387138897 cites W2266460037 @default.
• W4387138897 cites W2336673742 @default.
• W4387138897 cites W2401565151 @default.
• W4387138897 cites W2414193471 @default.
• W4387138897 cites W2498191157 @default.
• W4387138897 cites W2558549172 @default.
• W4387138897 cites W2566669267 @default.
• W4387138897 cites W2580322451 @default.
• W4387138897 cites W2585782726 @default.
• W4387138897 cites W2593370060 @default.
• W4387138897 cites W2605232463 @default.
• W4387138897 cites W2613043762 @default.
• W4387138897 cites W2749830411 @default.
• W4387138897 cites W2765813829 @default.
• W4387138897 cites W2770318055 @default.
• W4387138897 cites W2885976665 @default.
• W4387138897 cites W2886237438 @default.
• W4387138897 cites W2969845879 @default.
• W4387138897 cites W2987571151 @default.
• W4387138897 cites W3017321230 @default.
• W4387138897 cites W3102200137 @default.
• W4387138897 cites W3107278958 @default.
• W4387138897 cites W3216089921 @default.
• W4387138897 cites W3216752808 @default.
• W4387138897 cites W4200123533 @default.
• W4387138897 cites W4220960641 @default.
• W4387138897 cites W4249088156 @default.
• W4387138897 doi "https://doi.org/10.3390/ijms241914646" @default.
• W4387138897 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37834095" @default.
• W4387138897 hasPublicationYear "2023" @default.
• W4387138897 type Work @default.
• W4387138897 citedByCount "0" @default.
• W4387138897 crossrefType "journal-article" @default.
• W4387138897 hasAuthorship W4387138897A5005108774 @default.
• W4387138897 hasAuthorship W4387138897A5011657725 @default.
• W4387138897 hasAuthorship W4387138897A5032402958 @default.
• W4387138897 hasAuthorship W4387138897A5052627673 @default.
• W4387138897 hasAuthorship W4387138897A5062650631 @default.
• W4387138897 hasAuthorship W4387138897A5065600475 @default.
• W4387138897 hasAuthorship W4387138897A5067999055 @default.
• W4387138897 hasAuthorship W4387138897A5070729891 @default.
• W4387138897 hasAuthorship W4387138897A5080770364 @default.
• W4387138897 hasBestOaLocation W43871388971 @default.
• W4387138897 hasConcept C120504264 @default.
• W4387138897 hasConcept C121608353 @default.
• W4387138897 hasConcept C126322002 @default.
• W4387138897 hasConcept C143425029 @default.
• W4387138897 hasConcept C186000732 @default.
• W4387138897 hasConcept C203014093 @default.

• next